FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 4:15 AM GMTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Brilinta War: AstraZeneca, Dr Reddys in patent battle over generic version of ticagrelor Ruby Khatun Khatun27 July 2018 10:01 AM GMTNew Delhi: Dr Reddy's Laboratories has been dragged to Delhi High Court by AstraZeneca in order to block the firm from launching the generic versions...
